[HTML][HTML] Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study

…, P Filippidis, J Tschopp, F Desgranges, B Viala… - PLoS …, 2020 - journals.plos.org
Background This study aims to describe the epidemiology of COVID-19 patients in a Swiss
university hospital. Methods This retrospective observational study included all adult patients …

[HTML][HTML] Post‑COVID‑19 syndrome in outpatients: a cohort study

…, A Munting, J Regina, P Filippidis, B Viala… - Journal of General …, 2022 - Springer
Background After mild COVID-19, some outpatients experience persistent symptoms. However,
data are scarce and prospective studies are urgently needed. Objectives To characterize …

[HTML][HTML] Predicting venous thromboembolic events in patients with coronavirus disease 2019 requiring hospitalization: an observational retrospective study by the …

E Kampouri, P Filippidis, B Viala, M Méan… - BioMed research …, 2020 - hindawi.com
Background. Coronavirus disease 2019 (COVID-19) can result in profound changes in blood
coagulation. The aim of the study was to determine the incidence and predictors of venous …

[HTML][HTML] Cerebrospinal fluid HIV-1 escape in patients with neurocognitive symptoms: pooled data from a neuro-HIV platform and the NAMACO study

P Filippidis, J Damas, B Viala, F Assal… - JAIDS Journal of …, 2023 - journals.lww.com
Background: Despite modern antiretroviral therapy, human immunodeficiency virus-1 (HIV-1)
ribonucleic acid (RNA) escape into the cerebrospinal fluid (CSF) may occur. We examined …

[HTML][HTML] Impact of 2020 EUCAST criteria on meropenem prescription for the treatment of Pseudomonas aeruginosa infections: an observational study in a university …

…, A Kritikos, B Guery, L Senn, B Viala - Clinical Microbiology …, 2022 - Elsevier
Objectives We aimed to evaluate the impact of the 10th version of European Committee on
Antimicrobial Susceptibility Testing (EUCAST) breakpoints table, where most …

Assessment of the in vitro activities of ceftolozane/tazobactam and ceftazidime/avibactam in a collection of beta-lactam-resistant Enterobacteriaceae and …

B Viala, FZ Zaidi, M Bastide, Y Dumont… - Microbial Drug …, 2019 - liebertpub.com
Objective: To assess in vitro ceftolozane/tazobactam (C/T) and ceftazidime/avibactam (CZA)
activity in beta-lactam-resistant Enterobacteriaceae and Pseudomonas aeruginosa clinical …

One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV

…, A Berney, G Maccaferri, P Filippidis, B Viala… - HIV …, 2023 - Wiley Online Library
Background With ageing, comorbidities such as neurocognitive impairment increase among
people living with HIV (PLWH). However, addressing its multifactorial nature is time‐…

Reversing HIV latency via sphingosine-1-phosphate receptor 1 signaling

C Duquenne, S Gimenez, A Guigues, B Viala… - AIDS, 2017 - journals.lww.com
Objective: In this study, we looked for a new family of latency reversing agents. Design: We
searched for G-protein-coupled receptors (GPCR) coexpressed with the CC chemokine …

[HTML][HTML] Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections …

A Munting, J Damas, B Viala, G Prod'hom… - … Resistance & Infection …, 2022 - Springer
Background We previously reported an increase in meropenem prescriptions for Pseudomonas
aeruginosa infections in our hospital after the implementation of the 10th version of the …

Using the clinical information system and self-supervision to rationalize the need for antibiotic stewardship: an interventional study in a 2000-bed university hospital

B Viala, M Villiet, A Redor, MN Didelot… - International journal of …, 2021 - Elsevier
Objectives: To describe the usefulness of electronic medical records (EMRs) and a
computerized physician order entry (CPOE) system to support and assess an antimicrobial …